In the Philippines, access to effective and life-changing HIV treatment is crucial, and PULSE CLINIC (Social Enterprise), a leading social enterprise, is proud to offer Biktarvy, one of the most advanced and trusted HIV treatment options available today. If you or a loved one is living with HIV, Biktarvy can help manage your condition with a simple and effective daily regimen.
Biktarvy is a single-tablet, once-daily combination of three potent antiretroviral medications: Bictegravir, Emtricitabine, and Tenofovir alafenamide. This combination is designed to fight HIV by blocking the virus from replicating in the body. With proven effectiveness, Biktarvy not only helps reduce viral load but also supports a healthy immune system.
PULSE CLINIC (Social Enterprise), a trusted social enterprise committed to supporting the health and well-being of Filipinos, is dedicated to providing access to life-saving medications like Biktarvy at affordable prices. By choosing PULSE CLINIC (Social Enterprise) you're not only getting world-class care and treatment, but you're also supporting a social enterprise that reinvests profits into health initiatives across the country.
How to Order:
PULSE CLINIC (Social Enterprise) is more than just a healthcare provider—it’s a social enterprise focused on improving access to healthcare services and medications for everyone. By ordering from PULSE CLINIC (Social Enterprise), you’re contributing to a cause that helps make HIV treatment more accessible, affordable, and equitable in the Philippines.
With Biktarvy, you’re choosing a treatment option backed by science, proven in clinical studies, and trusted by healthcare professionals worldwide. Don't wait any longer to start your journey toward better health—contact PULSE CLINIC (Social Enterprise) today!
Contact PULSE CLINIC (Social Enterprise) today to schedule your consultation
and start your journey to a healthier future!
Go to the online booking website directly to book your consultation.
Or contact us at pulseliving@pulse-clinic.com or via your prefer platform.